20/20 Biolabs, Inc. Common Stock (AIDX)

20/20 Biolabs, Inc. Common Stock (AIDX) is a Medical Devices company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $3.3M; returns 1 day -6.2%, 1 week -9.7%.

20/20 Biolabs, Inc. (AIDX) is a commercial-stage diagnostics company focused on early disease detection through machine learning and proteomics. The company’s primary revenue driver is its OneTest brand, notably 'OneTest for Cancer,' a multi-cancer early detection (MCED) blood test that utilizes AI algorithms to analyze panels of protein biomarkers.

Groups AIDX belongs to

• Healthcare
• Recent IPOs
• Biotechnology
• Artificial Intelligence
• Machine Learning
• Medical Devices
• Early Cancer Detection
• Health Diagnostics and Imaging
• Clinical Stage
• Oncology
• AI in Healthcare
• Healthcare Technology
• Commercial Stage

AIDX financial model: income statement, cash flow and balance sheet